🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

One Dintwe

Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa

ORCID: 0000-0002-5642-7121

Also affiliated with Fred Hutch Cancer Center

Immunology and MicrobiologyMedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 14 papers. Top paper: “A phase 1b randomized study of the safety and immunological responses to vaccination with H4:IC31, H56:IC31, and BCG revaccination in Mycobacterium tuberculosis-uninfected adolescents in Cape Town, South Africa”.

A phase 1b randomized study of the safety and immunological responses to vaccination with H4:IC31, H56:IC31, and BCG revaccination in Mycobacterium tuberculosis-uninfected adolescents in Cape Town, South Africa

EClinicalMedicine(2020)10.1016/j.eclinm.2020.100313

N/A

2.3DataRank · unranked

75 citations

One Dintwe, Andrew Fioré-Gartland, Keren Middelkoop, Julia Hütter, Anthony Williams +16 more

Phase 1 Human Immunodeficiency Virus (HIV) Vaccine Trial to Evaluate the Safety and Immunogenicity of HIV Subtype C DNA and MF59-Adjuvanted Subtype C Envelope Protein

Clinical Infectious Diseases(2020)10.1093/cid/ciz1239

N/A

1.2DataRank · unranked

35 citations

Craig Innes, Sarita Naidoo, Philipp Mann, Julia Hütter, Gita Ramjee +69 more

Analysis of the HIV Vaccine Trials Network 702 Phase 2b–3 HIV-1 Vaccine Trial in South Africa Assessing RV144 Antibody and T-Cell Correlates of HIV-1 Acquisition Risk

The Journal of Infectious Diseases(2022)10.1093/infdis/jiac260

N/A

1.1DataRank · unranked

50 citations

One Dintwe, Sheetal Sawant, Doug Grove, Yunda Huang, Holly Janes +43 more

Safety and immunogenicity of a subtype C ALVAC-HIV (vCP2438) vaccine prime plus bivalent subtype C gp120 vaccine boost adjuvanted with MF59 or alum in healthy adults without HIV (HVTN 107): A phase 1/2a randomized trial

PLoS Medicine(2024)10.1371/journal.pmed.1004360

N/A

0.439DataRank · unranked

9 citations

Erica Andersen‐Nissen, Nicole Grunenberg, One Dintwe, Faatima Laher Omar, Jia Jin Kee +29 more

Protein Dose-Sparing Effect of AS01B Adjuvant in a Randomized Preventive HIV Vaccine Trial of ALVAC-HIV (vCP2438) and Adjuvanted Bivalent Subtype C gp120

The Journal of Infectious Diseases(2023)10.1093/infdis/jiad434

N/A

0.395DataRank · unranked

7 citations

Fatima Laher, One Dintwe, Monde Muyoyeta, Allan C. deCamp, Zonglin He +27 more

A polyvalent DNA prime with matched polyvalent protein/GLA-SE boost regimen elicited the most robust and broad IgG and IgG3 V1V2 binding antibody and CD4+ T cell responses among 13 HIV vaccine trials

Emerging Microbes & Infections(2025)10.1080/22221751.2025.2485317

N/A

0.260DataRank · unranked

4 citations

Shuying Sue Li, Elena Giorgi, LaTonya D. Williams, One Dintwe, Lindsay N. Carpp +34 more

Non-HIV Vaccine-Induced Immune Responses as Potential Baseline Immunogenicity Predictors of ALVAC-HIV and AIDSVAX B/E-Induced Immune Responses

Viruses(2024)10.3390/v16091365

N/A

0DataRank · unranked

2 citations

S. Munir Alam, Erica Andersen‐Nissen, Lindsay N. Carpp, One Dintwe, Britta Flach +12 more

Probing Dermal Immunity to Mycobacteria through a Controlled Human Infection Model

ImmunoHorizons(2024)10.4049/immunohorizons.2400053

N/A

0DataRank · unranked

1 citations

Emma Bishop, Andrew Fioré-Gartland, Krystle K. Q. Yu, Ming Chang, Richard M. Jones +20 more

Unbiased cell clustering analysis of vaccine-induced T cell responses in the Imbokodo HIV-1 vaccine trial

EBioMedicine(2025)10.1016/j.ebiom.2025.106017

N/A

0DataRank · unranked

1 citations

Janine van Duijn, Kanika Vanshylla, One Dintwe, Laura Pattacini, Faatima Laher Omar +13 more

Antibody and cellular responses to HIV vaccine regimens with DNA plasmid as compared with ALVAC priming: An analysis of two randomized controlled trials

PLoS Medicine(2020)10.1371/journal.pmed.1003117

N/A

0DataRank · unranked

14 citations

Stephen R. Walsh, Fatima Laher, Lucas Maganga, Michael E. Herce, Sarita Naidoo +28 more

Immune profiling of Mycobacterium tuberculosis -specific T cells in recent and remote infection

medRxiv(2020)10.1101/2020.11.13.20230946

N/A

0DataRank · unranked

1 citations

Virginie Rozot, Boitumelo Mosito, Munyaradzi Musvosvi, One Dintwe, Nicole Bilek +5 more

Immune profiling of Mycobacterium tuberculosis-specific T cells in recent and remote infection

EBioMedicine(2021)10.1016/j.ebiom.2021.103233

N/A

0DataRank · unranked

42 citations

Virginie Rozot, Boitumelo Mosito, Munyaradzi Musvosvi, One Dintwe, Nicole Bilek +4 more

Immune correlates analysis of the Imbokodo (HVTN 705/HPX2008) efficacy trial of a mosaic HIV-1 vaccine regimen evaluated in Southern African people assigned female sex at birth: a two-phase case-control study

EBioMedicine(2024)10.1016/j.ebiom.2024.105320

N/A

0DataRank · unranked

16 citations

Janine van Duijn, One Dintwe, Jack Heptinstall, Randy I. Burnham, Sheetal Sawant +93 more

Adolescent BCG revaccination induces a phenotypic shift in CD4+ T cell responses to Mycobacterium tuberculosis

Nature Communications(2024)10.1038/s41467-024-49050-1

N/A

0DataRank · unranked

8 citations

Lamar M. Fleming, Valentin Voillet, John McNevin, Aaron Seese, Anneta Naidoo +9 more